Inogona kuongororwa kenza yemuromo wechibereko inogona kuitwa makore ese mashanu?

Share This Post

Kuongororwa gomarara remuchibereko

Is it safe to extend the screening interval to 5 years or more after a negative screening result? A new study shows that the risk of cervical cancer after one or more combined HPV tests and cytology screening results is negative Is significantly reduced. The study found a follow-up analysis of 1 million female subjects. The analysis showed that the risk of invasive chirwere chemuviri wechibereko and cervical CIN3 lesions decreased with each round of combined testing and screening. This risk reduction is most significant between the first and second rounds, and is more significant than the second and third rounds. (Ann Intern Med. November 27, 2017 online version)

Mafambiro ekuongorora gomarara remuchibereko anga achichinja, kunyanya nejekiseni reHPV. The 2015 edition yeACOG nhungamiro inokurudzira kuti kuongororwa kweHPV kunogona kushandiswa seimwe nzira yekuongorora yevakadzi vanopfuura makore makumi maviri nemashanu. Inokurudzirwa kugamuchira cytology makore matatu oga oga. Zvinoratidzwa zvakare kuti yakasanganiswa cytology uye HPV kuyedzwa ndiyo inonyanya kufarirwa. Iyo USPSTF dhizaini dhizaini inokurudzira kuongororwa chete HPV yakakwirira-njodzi subtypes. Seimwe nzira kune iri nyore cytology yevakadzi vanopfuura makumi matatu, kuongororwa kwemajoini hakuchakurudzirwi.

Vatsvaguriri vakaratidza kuti hapana hunyanzvi hwekutsvagisa nezve kugona kweHIVV kuyedza, uye mazhinji ezvinyorwa zvakaburitswa zvekuongorora zveHVV zvinoenderana nekutenderera kwekutarisa. Vatsvagurudzo vakaongorora vakadzi mazana mapfumbamwe nemakumi mapfumbamwe nevatanhatu (990013) vaive vamboedzwa pamwechete kubva 2003 kusvika 2014, uye vakaongorora shanduko yenjodzi yemukondombera mushure mekunge mhedzisiro yekuteedzana kwekubatanidza kuyedza yakanga isina kunaka.

Ongororo yakawana kuti semhedzisiro yakaipa yebvunzo yakasanganiswa yakawedzera, njodzi yekenza yechibereko uye ≥CIN3 maronda akaenderera mberi achiderera, uye mhedzisiro yakaipa yekutanga yakasanganiswa bvunzo yaive nemhedzisiro yakakura pakudzikisa njodzi. Mune chero kutenderera kwekuongorora, mhedzisiro yeyakachena HPV bvunzo mhedzisiro panjodzi yegomarara inowirirana, zvisinei nemhedzisiro ye cytological test, zvisinei neyakasanganiswa mhinduro dzebvunzo. Avo vakanga vasina kunaka kwekutanga HPV bvunzo vakave ne5-gore kuderedzwa kweiyo invasive kenza yechibereko chechirwere che 0.0092%, uye avo vaive nechakaipa chechitatu bvunzo mhedzisiro vaive nekuderedzwa kwe0.0015% mungozi; Njodzi yemakore matatu yechirwere chegomarara remuromo wechibereko chaive chisina kunaka pabvunzo yekutanga neyechitatu Dzikire ne3% uye 0.0081%. Iyo yemakore matatu isina kunaka cytological njodzi yegomarara yakaderedzwa ne0.0015% uye 0.0140%, zvichiteerana.

Mumwe muongorori akataura kuti ongororo iyi yakaratidza kuti mukuyedzwa kwekutanga kwemajoini, vakadzi vane miedzo isina kunaka yeHIVV vaingova nenjodzi yakati pfuurei yekenza kupfuura avo vane miedzo yakaipa yakasanganiswa, uye avo vane mhedzisiro yakaipa yeHIVV muyedzo yechipiri yakasanganiswa zvakadzora njodzi chechitatu Mushure mechipiri chisina kunaka, zvakanyangarika zvakanyangarika. Mukutsvaga maronda eCIN3, zvakanakira kuyedzwa kwakabatana pamusoro pekuedzwa kweHIVV zvidiki kwazvo. Kuedzwa kwakabatana kunongowedzera zvisina kufanira colposcopy uye biopsy uye pamusoro pekurapwa. 

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kurapa Kwemasero eCAR T kunoitwa nevanhu: Kubudirira Uye Zvinetso
CAR T-Cell kurapa

Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso

Human-based CAR T-cell therapy inosandura kurapwa kwegomarara nekugadzirisa magene masero emuviri emurwere kuti anange nekuparadza maseru egomarara. Nekushandisa simba rekudzivirira kwemuviri, marapirwo aya anopa marapiro ane simba uye emunhu ane mukana wekuregererwa kwenguva refu mumhando dzakasiyana dzegomarara.

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa